Retina

AI-powered GPT-4 accurately evaluates patient eligibility for retina clinical trials

A customized version of GPT-4 has demonstrated high accuracy and sensitivity in determining patient eligibility for retina-specific clinical trials, suggesting that this technology could significantly streamline the process of qualifying patients for clinical research in ophthalmology, according to a poster presented at ASRS 2024. To conduct the study, publicly available...